Karyopharm Therapeutics clinical trials we track

Check company identity source

Phase 3 4 trials

Phase 2 / 3 1 trial

Phase 2 6 trials

Phase 1 / 2 1 trial

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 244 participants (planned). After: 279 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Dec 2026. After: 2 Jun 2026.

Recruitment status changed

Before: Active not recruiting. After: Terminated.

Check registry source

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 276 participants (planned). After: 257 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 3 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Proportion of Participants with Spleen Volume Reduction 35 (SVR35) at Week 24.. After: Measure: Proportion of Participants with Spleen Volume Reduction ≥35% (SVR35) at Week 24.

Planned enrollment decreased by 60 participants

Before: 118 participants (planned). After: 58 participants (planned).

Primary completion date changed

Before: Apr 2026. After: Jun 2027.

Check registry source